A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran.
Shahin SoltaniBehzad Karami MatinMohammad Mehdi GouyaSayed Mohsen ZahraeiGhobad MoradiOmid ChehriMoslem SoofiMahdi MoradinazarFatemeh Khosravi ShadmaniMahsa KalantariHamidreza KhajehaMohammad Hassan EmamianFarid NajafiPublished in: BMC public health (2023)
With the planned study we will provide a valid epidemiological evidence to improve the understanding of the safety of the booster dose of the AstraZeneca and to better evaluate the effectiveness of public health interventions. This could help policy makers in managing the COVID-19 pandemic according to scientific evidence.